Invention Grant
- Patent Title: Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
-
Application No.: US14726337Application Date: 2015-05-29
-
Publication No.: US09315488B2Publication Date: 2016-04-19
- Inventor: Hong Ding , Steven W. Elmore , Lisa Hasvold , Laura A. Hexamer , Aaron R. Kunzer , William J. McClellan , Andrew J. Souers , Gerard M. Sullivan , Zhi-Fu Tao , Michael D. Wendt
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: ABBVIE INC.
- Current Assignee: ABBVIE INC.
- Current Assignee Address: US IL North Chicago
- Agency: Jones Day
- Main IPC: C07D295/155
- IPC: C07D295/155 ; C07D209/08 ; C07D211/58 ; C07D401/12 ; C07D309/04
Abstract:
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 or Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti-apoptotic Bcl-2 protein.
Public/Granted literature
- US20160009687A1 BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES Public/Granted day:2016-01-14
Information query
